Research library

A

grade

This pilot study suggests that a self-management intervention for prostate cancer patients with diabetes is feasible and may improve diabetes management, but further research is needed.

> 75% engagement and average acceptability score of 37.3/56.

summary

B

grade

Discontinuation of adjuvant endocrine therapy due to toxicity can lead to rapid cancer progression, underscoring the need for careful management and monitoring.

summary

A

grade

Leuprolide may provide better PSA reduction, but it also leads to more hot flashes compared to goserelin, which has its own cardiovascular risks.

Not reported in abstract.

summary

B

grade

Clinicians should be aware of potential pancreatic cancer risks associated with certain medications, especially in patients over 45 years of age.

Median weight for GLP-1 analogues was 91 kg, and for compound hypoglycemic agents was 82 kg, p < 0.01.

summary

B

grade

This study highlights potential biomarkers in prostate cancer but emphasizes the need for larger, multicenter studies to validate these findings before clinical application.

Corrected mean AUC was 0.725 (95% CI: 0.58-0.87).

summary

A

grade

Fovinaciclib significantly improves progression-free survival in hormone receptor-positive, ERBB2-negative advanced breast cancer, with manageable safety, but long-term survival benefits remain unclear.

Median PFS not reached vs 20.2 months with placebo, HR 0.55, 95% CI 0.38-0.77, 1-sided P < .001.

summary

B

grade

Risk perception and decision-making for surgery in genetically predisposed individuals are influenced by both objective information and personal factors, with healthcare providers playing a key role.

63 surveys and 20 interviews completed.

summary

B

grade

Goserelin and leuprolide show similar efficacy in estrogen reduction for premenopausal breast cancer patients, but leuprolide may increase the risk of liver issues while goserelin may affect thyroid function.

88.89% of leuprolide patients achieved substantial estrogen reduction vs 92.78% of goserelin patients, RD = -3.89%, 95% CI: -12.18% to 4.40%; p = 0.354.

summary

C

grade

IGF-1 overexpression in a mouse model of SBMA showed promising effects on reducing AR aggregation and improving lifespan, but results may not directly apply to humans.

Not reported in abstract.

summary

A

grade

The combination of darolutamide and goserelin showed a higher objective response rate and longer progression-free survival compared to darolutamide alone in patients with androgen receptor-positive salivary gland carcinoma.

Confirmed ORR of 45.2% (90% CI, 29.7 to 61.3) in the combination cohort, n=33.

summary

B

grade

A 69-year-old man with metastatic hormone-sensitive prostate cancer achieved a significant reduction in PSA levels after treatment with goserelin and 177 Lu-PSMA therapy, but further research is needed to confirm these findings.

PSA reduced from 433.75 ng/mL to 0.15 ng/mL after treatment.

summary

B

grade

Lifestyle habits significantly influence breast cancer survival, with age and BMI being critical factors. This study provides a foundation for integrating health indicators into risk assessment models.

3-year AUC = 0.72 for breast cancer survival prediction.

summary

B

grade

Abiraterone combined with LHRH agonists rapidly achieves castration-level testosterone, potentially eliminating the need for anti-androgen pretreatment in prostate cancer therapy.

100% of patients achieved castration-level testosterone by Day 28.

summary

B

grade

Leuprorelin 3-month depot is as effective as other treatments for CPP and may improve compliance due to reduced injection frequency.

No statistically significant differences were noted in the baseline levels of sex hormones or growth metrics among the groups (P>0.05).

summary

B

grade

Prescription rationality in oncology treatment is improving for traditional Chinese medicine but remains problematic for some modern medicines like Goserelin.

1.9 million prescriptions sampled for 2020-2021.

summary

C

grade

This study demonstrates that organoid-xenograft models can effectively mimic prostate cancer progression and identify potential biomarkers for aggressive subtypes.

Not reported in abstract.

summary

D

grade

Not reported in abstract.

summary

D

grade

Not reported in abstract.

summary

B

grade

Liver biopsy provides limited additional diagnostic value in ANA-positive patients with mild liver enzyme elevation, particularly when alanine aminotransferase is below 101 U/L.

9% showed autoimmune hepatitis compatible histology among patients with positive antinuclear antibodies and alanine aminotransferase < 101 U/L.

summary

A

grade

About one-fourth of stage IV breast cancer patients show differing treatment responses between primary and metastatic sites, which can significantly impact survival outcomes.

HR 0.556; 95% confidence interval, 0.396–0.782.

summary

B

grade

Long-term surveillance of the vaginal stump is crucial for early detection of lesions in patients who have undergone total hysterectomy for benign diseases.

Not reported in abstract.

summary

A

grade

Linzagolix showed comparable efficacy to leuprorelin for reducing menstrual bleeding in women with uterine leiomyomas, with a quicker onset of action.

89.9% of patients in the linzagolix group had a total PBAC score <10 from Weeks 6 to 12, 95% CI 83.7, 94.4.

summary

B

grade

Despite limited objective height benefits, 72% of participants reported satisfaction with height-related outcomes, highlighting the importance of managing expectations in CPP treatment.

72% satisfied with height-related outcomes.

summary

A

grade

Hormonal therapies for endometriosis may lead to a decrease in bone mineral density, but the clinical significance of this finding is unclear and warrants further investigation.

-1.50% BMD at 12 months, 95% CI -2.68 to -0.31, I2 =40.5%, n=4 studies

summary